IRIS
PICARDI, ANTONIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 14.692
NA - Nord America 4.545
EU - Europa 2.067
SA - Sud America 630
AF - Africa 101
OC - Oceania 29
Continente sconosciuto - Info sul continente non disponibili 2
Totale 22.066
Salva come PNG Salva come JPEG
Nazione #
SG - Singapore 11.029
US - Stati Uniti d'America 4.322
CN - Cina 1.606
IT - Italia 971
HK - Hong Kong 951
BR - Brasile 447
BD - Bangladesh 339
VN - Vietnam 310
GB - Regno Unito 283
FR - Francia 259
DE - Germania 169
IN - India 119
CA - Canada 107
MX - Messico 72
AR - Argentina 70
FI - Finlandia 60
NL - Olanda 58
ID - Indonesia 50
TR - Turchia 46
PL - Polonia 41
ES - Italia 37
ZA - Sudafrica 36
RU - Federazione Russa 34
UA - Ucraina 34
EC - Ecuador 33
AU - Australia 27
CZ - Repubblica Ceca 25
SA - Arabia Saudita 24
IQ - Iraq 22
JP - Giappone 22
PH - Filippine 21
PK - Pakistan 21
CO - Colombia 17
MY - Malesia 17
CL - Cile 16
VE - Venezuela 14
CH - Svizzera 13
JM - Giamaica 13
SE - Svezia 12
MA - Marocco 11
PY - Paraguay 11
PE - Perù 10
UZ - Uzbekistan 10
EG - Egitto 8
NP - Nepal 8
AE - Emirati Arabi Uniti 7
BE - Belgio 7
BH - Bahrain 7
JO - Giordania 7
OM - Oman 7
SY - Repubblica araba siriana 7
TH - Thailandia 7
AT - Austria 6
AZ - Azerbaigian 6
DO - Repubblica Dominicana 6
IE - Irlanda 6
LB - Libano 6
LT - Lituania 6
UY - Uruguay 6
AL - Albania 5
BO - Bolivia 5
BY - Bielorussia 5
DK - Danimarca 5
DZ - Algeria 5
HN - Honduras 5
KE - Kenya 5
TN - Tunisia 5
AO - Angola 4
BA - Bosnia-Erzegovina 4
CY - Cipro 4
ET - Etiopia 4
HU - Ungheria 4
IL - Israele 4
KR - Corea 4
KZ - Kazakistan 4
MD - Moldavia 4
NI - Nicaragua 4
TT - Trinidad e Tobago 4
AM - Armenia 3
BG - Bulgaria 3
CR - Costa Rica 3
IR - Iran 3
KH - Cambogia 3
RS - Serbia 3
CM - Camerun 2
EE - Estonia 2
GT - Guatemala 2
HT - Haiti 2
IS - Islanda 2
KW - Kuwait 2
LA - Repubblica Popolare Democratica del Laos 2
LK - Sri Lanka 2
MN - Mongolia 2
MW - Malawi 2
RO - Romania 2
SI - Slovenia 2
SN - Senegal 2
TL - Timor Orientale 2
XK - ???statistics.table.value.countryCode.XK??? 2
YE - Yemen 2
Totale 22.030
Salva come PNG Salva come JPEG
Città #
San Jose 1.449
Singapore 1.044
Hong Kong 932
Ashburn 919
Rome 694
Hefei 495
Beijing 388
Boardman 265
Dallas 231
Lauterbourg 221
London 206
Shanghai 195
Ho Chi Minh City 118
Santa Clara 93
Los Angeles 90
Munich 87
New York 81
Council Bluffs 73
San Francisco 62
Hanoi 55
São Paulo 52
Mexico City 51
Toronto 44
Seattle 43
West Jordan 41
Turku 38
Warsaw 37
Amsterdam 34
Washington 34
Pune 32
Buffalo 24
Montreal 23
Brno 22
Chennai 22
Helsinki 22
Orem 21
Rio de Janeiro 21
Sona 20
Brooklyn 19
Guangzhou 19
Manchester 19
Boston 17
Johannesburg 17
Milan 17
Tokyo 17
Frankfurt am Main 16
Haiphong 16
Atlanta 14
Paris 14
Charlotte 13
Naples 13
Riyadh 13
Brasília 12
Chicago 12
Da Nang 12
Guayaquil 12
Central 11
Lahore 11
Melbourne 11
Kuala Lumpur 10
Las Vegas 10
Quito 10
Stockholm 10
Tashkent 10
Thái Bình 10
Bologna 9
Canberra 9
Curitiba 8
Denver 8
Hangzhou 8
Istanbul 8
Moscow 8
Mumbai 8
New Delhi 8
Phoenix 8
Zhengzhou 8
Belo Horizonte 7
Pasadena 7
Amman 6
Ankara 6
Bari 6
Brescia 6
Campinas 6
Haikou 6
Jakarta 6
Jinan 6
Kingston 6
Kyiv 6
Medellín 6
Muscat 6
Ninh Bình 6
Poplar 6
Redmond 6
Secaucus 6
Baghdad 5
Baku 5
Bangkok 5
Berlin 5
Bogotá 5
Buenos Aires 5
Totale 8.874
Salva come PNG Salva come JPEG
Nome #
Approaching the Sarcopenic Patient with Nonalcoholic Steatohepatitis-related Cirrhosis 248
Altered metal metabolism in patients with HCV-related cirrhosis and hepatic encephalopathy 247
A case of Henoch-Schönlein purpura in the elderly: not just a 'second childhood' 246
A mocking finding: portal cavernoma mimicking neoplastic mass. First sign of myeloproliferative disorder in a patient with Janus kinase2 V617F mutation 240
[Protective effect of verapamil in myocardial hypertrophy due to aortic stenosis experimentally induced in the rat] 232
Angiogenic cytokines in patients undergoing antiviral treatment for chronic hepatitis C virus infection 230
Deep vein thrombosis, inferior vena cava interruption and multiple thrombophilic gene mutations 230
Apoptosis and autoimmunity induced by clodronate in systemic lupus erythematosus mononuclear circulating cells 229
S-Adenosylmethionine (AdoMet) supplementation for treatment of chemotherapy-induced liver injury 229
Iloprost: an adjunctive approach to chronic viral hepatitis treatment 228
Anti-tumor necrosis factor-alpha reverts growth hormone resistance associated with inflammatory bowel disease 225
Choice and Outcomes of Rate Control versus Rhythm Control in Elderly Patients with Atrial Fibrillation: A Report from the REPOSI Study 225
Breath-print analysis by e-nose for classifying and monitoring chronic liver disease: a proof-of-concept study 225
[Consensus interferon: a new weapon in the treatment of chronic hepatitis C] 224
METAL HOMEOSTASIS IN PATIENTS WITH PORTO-SYSTEMIC ENCEPHALOPATHY 224
Breath-print analysis by e-nose may refine risk stratification for adverse outcomes in cirrhotic patients 223
Immune complexed (IC) hepatitis C virus (HCV) in chronically and acutely HCV-infected patients 221
Hepatic expression of lysosomal acid lipase is reduced in non-alcoholic fatty liver disease and inversely associated with the degree of microvescicular steatosis, impairment of the autophagic process and NAFLD activity score 218
Retroperitoneal fibrosis and ankylosing spondylitis: which links? 214
Distortion-product otoacoustic emissions: a useful test for monitoring ototoxicity induced by pegylated interferon and ribavirin treatment in patients with chronic hepatitis C 214
Adherence to antibiotic treatment guidelines and outcomes in the hospitalized elderly with different types of pneumonia 214
Combined evaluation of aminotransferases improves risk stratification for overall and cause-specific mortality in older patients 214
Development and Validation of a Scoring System to Predict Response to Obeticholic Acid in Primary Biliary Cholangitis 211
Hepatic Lysosomal Acid Lipase and lipophagy in the progression of NAFLD 211
Implementation of the Frailty Index in hospitalized older patients: Results from the REPOSI register 208
The hepatic expression of lysosomal acid lipase (LAL) is reduced in NAFLD patients, and associated with features of genetically determined LAL deficiency and NAFLD activity score 208
Granulomatous thyroiditis: an unexpected finding leading to the diagnosis of sarcoidosis 208
Impairment of GH/IGF-1 Axis in the liver of patients with hcv-related chronic hepatitis 205
BREATH PRINT ANALYSIS BY E-NOSE IS ASSOCIATED WITH ADVERSE OUTCOMES OF CIRRHOTIC PATIENTS INDEPENDENTLY FROM THE OTHER PROGNOSTIC INDICES 203
Assessment of liver function by the exhaled breath-print during chronic liver disease 202
Polypharmacy in older people: Lessons from 10 years of experience with the REPOSI register 200
Blood glucose monitoring in the normal population: the PREDICA study 197
Hepatitis A virus in a medical setting in Madagascar: a lesson for public health 197
[Hepatocarcinoma: from epidemiology to gene therapy] 195
Final Results from the First European Real-World Experience on Lusutrombopag Treatment in Cirrhotic Patients with Severe Thrombocytopenia: Insights from the REAl-World Lusutrombopag Treatment in ITalY Study 194
ALEX (R) (artificial liver for extracorporeal xenoassistance): A new bioreactor containing a porcine autologous biomatrix as hepatocyte support. Preliminary results in an ex vivo experimental model 193
Frequency of diabetes and thyroid autoantibodies in patients with autoimmune endocrine disease from Cameroon 187
Prevalence of use and appropriateness of antidepressants prescription in acutely hospitalized elderly patients 175
THU-390 - Hepatic expression of lysosomal acid lipase is reduced in non-alcoholic fatty liver disease and inversely associated with the degree of microvescicular steatosis, impairment of the autophagic process and NAFLD activity score 172
Cardiotrophin-1 is not associated with carotid or coronary disease and is inversely associated with obesity in patients undergoing coronary angiography 169
Accuracy of controlled attenuation parameter for assessing liver steatosis in individuals with morbid obesity before bariatric surgery 153
Anestesia e malattie non comuni 137
Liver cirrhosis after prolonged therapy with IFN-alpha plus interleukin-2 in a metastatic renal cancer long-term survivor 136
Coexistence of HBsAg and HBsAb in a difficult-to-treat chronic hepatitis B: loss of HBsAg with entecavir plus tenofovir combination 135
Diabetes in chronic liver disease: from old concepts to new evidence 134
Drug–drug interactions involving CYP3A4 and p-glycoprotein in hospitalized elderly patients 133
Exhaled breath analysis in hepatology: State-of-the-art and perspectives 132
[A 73-year-old woman with vomiting and metabolic alkalosis] 132
Acoustic Radiation Forced Impulse of the Liver and the Spleen, Combined with Spleen Dimension and Platelet Count in New Ratio Scores, Identifies High-Risk Esophageal Varices in Well-Compensated Cirrhotic Patients 131
Improved hepatic perfusion after iloprost infusion in patients with HCV chronic infection: a pilot study with possible therapeutic implications 131
Growth hormone-stimulated insulin-like factor-1 and acid labile subunit in chronic liver disease 130
A challenging alfa-fetoprotein in a cirrhotic patient 129
GH-resistance in different stages of chronic liver disease 127
Effectiveness of group medical nutrition therapy in lowering HbA(1c) in type 2 diabetes 127
Percutaneous ultrasound-guided ablation of BW7756-hepatoma using ethanol or acetic acid in a rat model 126
[A 74-year-old woman with macrocytic anemia] 126
Altered intestinal transport of amino acids in cirrhotic rats: the effect of insulin-like growth factor-I 125
Prevalence and Determinants of the Use of Lipid-Lowering Agents in a Population of Older Hospitalized Patients: the Findings from the REPOSI (REgistro POliterapie Società Italiana di Medicina Interna) Study 124
[A 61-year-old woman with abdominal pain and urination disorders] 124
Enhanced portal flow velocity and volume following Iloprost treatment 124
Pancreatitis after percutaneous ethanol injection into HCC: a minireview of the literature 120
A potential experimental model for the study of osteopenia in CCl4 liver cirrhotic rats 120
Association between non-invasive liver fibrosis scores and occurrence of health adverse outcomes in older people 119
METAL METABOLISM IMPAIRMENT IN PATIENTS WITH HEPATIC ENCEPHALOPATHY 118
Iloprost enhances portal flow velocity and volume in patients with systemic sclerosis 116
Antihypertensive treatment changes and related clinical outcomes in older hospitalized patients 115
Anesthesia & uncommon diseases 115
Radiofrequency ablation of hepatic tissue: a new experimental animal model 115
Prognostic value of degree and types of anaemia on clinical outcomes for hospitalised older patients 114
Determinants of alanine aminotransferase levels in a large population from Southern Italy: relationship between alanine aminotransferase and age 114
[Ramipril and new therapeutic possibilities for ACE-inhibitors] 113
Portal diameter in the diagnosis of esophageal varices in 266 cirrhotic patients: which role? 112
Breathprinting of liver diseases 109
Development of a new bioartificial liver using a porcine autologous biomatrix as hepatocyte support 108
Diagnostic value of Virtual Touch Quantification (VTQ®) for differentiation of hemangiomas from malignant focal liver lesions 108
The PNPLA3 rs738409 variant can increase the risk of liver toxicity in multiple sclerosis patients treated with beta-interferon 106
Donna di 35 anni con febbre, dispnea e dolore alla coscia sinistra [A 35-year-old woman with fever, dyspnea, and pain in the left thigh]. 106
Pain and Frailty in Hospitalized Older Adults 106
A Polygenic Risk Score to Refine Risk Stratification and Prediction for Severe Liver Disease by Clinical Fibrosis Scores 106
Association between clinical scores of liver fibrosis and adverse non-hepatic outcomes: The key in the holistic vision of the patient 104
Platelet Count Does Not Predict Bleeding in Cirrhotic Patients: Results from the PRO-LIVER Study 103
Current Treatment Options for HCC: From Pharmacokinetics to Efficacy and Adverse Events in Liver Cirrhosis 103
Endothelial dysfunction and activation as an expression of disease: role of prostacyclin analogs 103
Matched-Pair Analysis of Transplant from Haploidentical, Unmanipulated Bone Marrow Donor versus HLA Identical Sibling for Patients with Hematologic Malignancies: Haploidentical vs HLA Identical Transplantation in Hematologic Malignancies 103
Clinical features and outcomes of elderly hospitalised patients with chronic obstructive pulmonary disease, heart failure or both 102
Hyperglycemia at admission, comorbidities, and in-hospital mortality in elderly patients hospitalized in internal medicine wards: data from the RePoSI Registry 101
Development and Validation of a Score for Fibrotic Nonalcoholic Steatohepatitis 98
LIVER TOXICITY IN COLORECTAL CANCER PATIENTS TREATED WITH FIRST LINE FOLFIRI-CONTAINING REGIMEN: A SINGLE INSTITUTION EXPERIENCE 96
Association between non-alcoholic fatty liver disease and cardiovascular disease: a first message should pass 95
Hospital Care of Older Patients With COPD: Adherence to International Guidelines for Use of Inhaled Bronchodilators and Corticosteroids 94
Adherence to antithrombotic therapy guidelines improves mortality among elderly patients with atrial fibrillation: insights from the REPOSI study 91
Combining genetic variants to improve risk prediction for nafld and its progression to cirrhosis: a proof of concept study 89
An overview of deregulated lipid metabolism in nonalcoholic fatty liver disease with special focus on lysosomal acid lipase 88
Brain and kidney, victims of atrial microembolism in elderly hospitalized patients? Data from the REPOSI study 88
Rapid virological response as a predictor of sustained response in HCV-infected patients with persistently normal alanine aminotransferase levels: A multicenter study 85
Pattern of comorbidities and 1-year mortality in elderly patients with COPD hospitalized in internal medicine wards: data from the RePoSI Registry 82
Defining aging phenotypes and related outcomes: Clues to recognize frailty in hospitalized older patients 79
Thrombocytopenia in chronic liver disease: Physiopathology and new therapeutic strategies before invasive procedures 76
The PREDICA study (PREdiction of diabetes from CApillary Blood Glucose) in the general population 75
Prognostication in NAFLD: physiological bases, clinical indicators, and newer biomarkers 73
Totale 15.219
Salva come PNG Salva come JPEG
Categoria #
all - tutte 128.859
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 128.859
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022394 0 2 9 0 3 3 4 5 35 10 5 318
2022/2023118 21 1 3 5 5 5 15 4 3 8 45 3
2023/2024824 51 54 25 78 77 333 3 37 13 76 28 49
2024/202512.233 146 74 306 50 192 279 163 39 646 801 4.413 5.124
2025/20268.570 773 390 548 874 357 477 2.246 517 652 769 613 354
Totale 22.139